Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Oct 15, 2015 (11 years ago)

Dryses Aluminum Chlorohydrate Antiperspirant Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations; product does not comply with cGMP requirements

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Dryses Aluminum Chlorohydrate Antiperspirant Solution, 3.4 fl. oz (100 mL) bottle, over the counter, Manufactured by Sesderma S.L., Valencia, Spain, NDC 63181-0015-1, UPC 8 470003 244268

Affected NDC 63181-0015-01

Compare with the code on your package — it is the most precise check available.

Recalling firm
Sesderma, SL
NDC code
63181-0015-1
Origin
N/A, Spain
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0842-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Sesderma, SL

All 2015 recalls
Class II · Moderate risk

Repaskin 30

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0010-1 D-0849-2016
Class II · Moderate risk

Repaskin 50

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0011-1 D-0848-2016

Other cgmp deviation recalls from 2015

All cgmp deviation recalls
Class II · Moderate risk

Oxygen

cGMP Deviations; trailer may not have met GMP requirements prior to filling

Terminated cGMP deviation AGA Gas Inc NDC 33237-001-01 D-0779-2016
Class II · Moderate risk

Repaskin 30

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0010-1 D-0849-2016